BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

798 related articles for article (PubMed ID: 25835982)

  • 1. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery.
    Praveenraj P; Gomes RM; Kumar S; Karthikeyan P; Shankar A; Parthasarathi R; Senthilnathan P; Rajapandian S; Palanivelu C
    Obes Surg; 2015 Nov; 25(11):2078-87. PubMed ID: 25835982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Liver Fibrosis and its Association with Non-invasive Fibrosis and Metabolic Markers in Morbidly Obese Patients with Vitamin D Deficiency.
    Luger M; Kruschitz R; Kienbacher C; Traussnigg S; Langer FB; Schindler K; Würger T; Wrba F; Trauner M; Prager G; Ludvik B
    Obes Surg; 2016 Oct; 26(10):2425-32. PubMed ID: 26989059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Predictors of Non-alcoholic Steatohepatitis and Its Severity in Individuals Undergoing Bariatric Surgery.
    Ayres ABS; Carneiro CRG; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2024 Feb; 34(2):456-466. PubMed ID: 38097891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The spectrum of non alcoholic fatty liver disease in morbidly obese patients: prevalence and associate risk factors.
    Feijó SG; Lima JM; Oliveira MA; Patrocínio RM; Moura-Junior LG; Campos AB; Lima JW; Braga LL
    Acta Cir Bras; 2013 Nov; 28(11):788-93. PubMed ID: 24316747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and characteristics of individuals without diabetes and hypertension who underwent bariatric surgery: lessons learned about metabolically healthy obese.
    Lee CJ; Clark JM; Asamoah V; Schweitzer M; Magnuson T; Lazo M
    Surg Obes Relat Dis; 2015; 11(1):142-6. PubMed ID: 25443068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and predictors of nonalcoholic steatohepatitis in obese patients undergoing bariatric surgery: a Department of Defense experience.
    Reha JL; Lee S; Hofmann LJ
    Am Surg; 2014 Jun; 80(6):595-9. PubMed ID: 24887798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of Scores Assessing Histological Activity and Estimated Long-Term Risk Analysis of Hepatic Decompensation of Non-Alcoholic Fatty Liver Disease in Individuals Undergoing Bariatric Surgery.
    Hatto M; Ivano VK; Gestic MA; Utrini MP; Chaim FDM; Callejas-Neto F; Chaim EA; Cazzo E
    Obes Surg; 2023 May; 33(5):1580-1586. PubMed ID: 37004688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transaminase Concentrations Cannot Separate Non-Alcoholic Fatty Liver and Non-Alcoholic Steatohepatitis in Morbidly Obese Patients Irrespective of Histological Algorithm.
    Lemmer P; Selbach N; Baars T; Porsch-Özcürümez M; Heider D; Canbay A; Sowa JP
    Dig Dis; 2022; 40(5):644-653. PubMed ID: 34469884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of bariatric surgery on NAFLD/NASH: a single-centre observational prospective cohort study.
    Theel WB; Boxma-de Klerk BM; Dirksmeier-Harinck F; van Rossum EF; Kanhai DA; Apers JA; van Dalen BM; De Knegt RJ; Neecke B; van der Zwan EM; Grobbee DE; Hankemeier T; Wiebolt J; Castro Cabezas M
    BMJ Open; 2023 Jul; 13(7):e070431. PubMed ID: 37400234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.
    Tai CM; Huang CK; Tu HP; Hwang JC; Chang CY; Yu ML
    Surg Obes Relat Dis; 2015; 11(4):888-94. PubMed ID: 25240529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of non-alcoholic steatohepatitis in patients with morbid obesity before bariatric surgery: preliminary evaluation with acoustic radiation force impulse imaging.
    Guzmán-Aroca F; Frutos-Bernal MD; Bas A; Luján-Mompeán JA; Reus M; Berná-Serna Jde D; Parrilla P
    Eur Radiol; 2012 Nov; 22(11):2525-32. PubMed ID: 22648049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population-based study on the prevalence of NASH using scores validated against liver histology.
    Hyysalo J; Männistö VT; Zhou Y; Arola J; Kärjä V; Leivonen M; Juuti A; Jaser N; Lallukka S; Käkelä P; Venesmaa S; Simonen M; Saltevo J; Moilanen L; Korpi-Hyövalti E; Keinänen-Kiukaanniemi S; Oksa H; Orho-Melander M; Valenti L; Fargion S; Pihlajamäki J; Peltonen M; Yki-Järvinen H
    J Hepatol; 2014 Apr; 60(4):839-46. PubMed ID: 24333862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT).
    Kalra S; Vithalani M; Gulati G; Kulkarni CM; Kadam Y; Pallivathukkal J; Das B; Sahay R; Modi KD
    J Assoc Physicians India; 2013 Jul; 61(7):448-53. PubMed ID: 24772746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Non-Alcoholic Fatty Liver Disease on Weight Loss and Resolution of Obesity-Related Disorders After Bariatric Surgery.
    Abdalla TSA; Giannou AD; Abdalla ASA; Izbicki JR; Dupreé A; Mann O; Wolter S
    World J Surg; 2023 Dec; 47(12):3281-3288. PubMed ID: 37747548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD).
    Verma S; Jensen D; Hart J; Mohanty SR
    Liver Int; 2013 Oct; 33(9):1398-405. PubMed ID: 23763360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological and immunohistochemical assessment of liver biopsies in morbidly obese patients.
    Caballero T; Gila A; Sánchez-Salgado G; Muñoz de Rueda P; León J; Delgado S; Muñoz JA; Caba-Molina M; Carazo A; Ruiz-Extremera A; Salmerón J
    Histol Histopathol; 2012 Apr; 27(4):459-66. PubMed ID: 22374723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and outcome of non-alcoholic fatty liver disease in adolescents and young adults undergoing weight loss surgery.
    Corey KE; Stanley TL; Misdraji J; Scirica C; Pratt J; Hoppin A; Misra M
    Pediatr Obes; 2014 Oct; 9(5):e91-3. PubMed ID: 24677740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonalcoholic fatty liver disease in morbidly obese subjects: correlation among histopathologic findings, biochemical features, and ultrasound evaluation.
    Cazzo E; de Felice Gallo F; Pareja JC; Chaim EA
    Obes Surg; 2014 Apr; 24(4):666-8. PubMed ID: 24415281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significant fibrosis assessed by liver biopsy among Chinese bariatric surgery patients: A prospective cross-sectional study.
    Huang Y; Dong S; Wang C; Dong Z; Chen W
    Front Endocrinol (Lausanne); 2023; 14():1090598. PubMed ID: 36793287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.